Your browser doesn't support javascript.
loading
Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer.
Liao, Jiatao; Lai, Hongyan; Liu, Chang; Zhang, Xin; Ou, Qiuxiang; Li, Qiaojuan; Li, Yan; Wang, Zhen; Liu, Cuicui; Wu, Xianghua; Wang, Huijie; Yu, Hui; Sun, Si; Zhao, Xinmin; Hu, Zhihuang; Zhang, Yao; Lin, Ying; Yu, Bo; Huang, Shenglin; Wang, Jialei.
  • Liao J; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Lai H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu C; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang X; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Ou Q; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li Q; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Li Y; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Liu C; Geneseeq Research Institute, Nanjing Geneseeq Technology., Nanjing, Jiangsu, China.
  • Wu X; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang H; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yu H; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Sun S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhao X; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Hu Z; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Zhang Y; Geneseeq Research Institute, Nanjing Geneseeq Technology., Nanjing, Jiangsu, China.
  • Lin Y; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Yu B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
  • Huang S; Department of Thoracic Medical Oncology, Fudan University Shanghai Cancer Center, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Wang J; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cancer Sci ; 114(7): 2774-2786, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37014183
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vesículas Extracelulares / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vesículas Extracelulares / Adenocarcinoma del Pulmón / Neoplasias Pulmonares Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article